Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Catalyst Pharmaceuticals Inc
CPRXCurrent price
19.88 USD
+0.04 USD (+0.20%)
Last closed
20 USD
Company
www.catalystpharma.com
ISIN
US14888U1016
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
2 359 517 440 USD
Yield for 12 month
+64.43 %
1Y
3Y
5Y
10Y
15Y
CPRX
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS); and Ruzurgi for the treatment of pediatric LEMS patients. The company develops Firdapse for the treatment of MuSK antibody positive myasthenia gravis and spinal muscular atrophy type. It has license agreements with BioMarin Pharmaceutical Inc.; and collaboration and license agreement with Endo Ventures Limited for the development and commercialization of generic Sabril tablets. The company was founded in 2002 and is based in Coral Gables, Florida. Address: 355 Alhambra Circle, Coral Gables, FL, United States, 33134
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
30.14 USDP/E ratio
35.5Dividend Yield
–Current Year
+398 204 000 USD
Last Year
+214 203 000 USD
Current Quarter
+122 710 000 USD
Last Quarter
+98 509 000 USD
Current Year
+313 672 000 USD
Last Year
+179 810 000 USD
Current Quarter
+97 961 000 USD
Last Quarter
+85 989 000 USD
Key Figures CPRX
1 year
3 years
5 years
10 years
EBITDA
122 452 000 USD
Operating Margin TTM
PE Ratio
35.5
Return On Assets TTM
9.33 %
PEG Ratio
–
Return On Equity TTM
13.85 %
Wall Street Target Price
30.14 USD
Revenue TTM
434 475 008 USD
Book Value
5.14 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
23.2 %
Dividend Yield
–
Gross Profit TTM
160 021 000 USD
Earnings per share
0.56 USD
Diluted Eps TTM
0.56 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
15.69 %
Dividend Analytics CPRX
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History CPRX
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation CPRX
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
35.5
Forward PE
9.7656
Enterprise Value Revenue
4.5738
Price Sales TTM
5.4307
Enterprise Value EBITDA
16.2284
Price Book MRQ
3.8766
Financials CPRX
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators CPRX
For 52 weeks
11.73 USD
21.67 USD
50 Day MA
19.21 USD
Shares Short Prior Month
5 773 097
200 Day MA
16.37 USD
Short Ratio
6.2
Shares Short
5 919 900
Short Percent
6.19 %
BeatStart